Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James W Dear

Showing results (1-10 of 140) with videos related to

Pageof 14
Sort By:
Clinical Toxicology (Philadelphia, Pa.)|October 26, 2010
New marker for paracetamol poisoning-revolution or evolution?James W Dear
British Journal of Clinical Pharmacology|December 6, 2022
Fomepizole should not be used more liberally in paracetamol overdoseJames W Dear
Ebiomedicine|September 8, 2019
Gastrointestinal AEs seen in the POP trial due to SOD mimetic activity of calmangafodipir? - Authors' replyJames W Dear
Journal of the American Society of Nephrology : JASN|April 5, 2014
Urinary exosomes join the fight against infectionJames W Dear
Hepatology (Baltimore, Md.)|March 4, 2018
New biomarkers for drug-induced liver injuryJames W Dear
Clinical Toxicology (Philadelphia, Pa.)|September 28, 2023
Novel biomarkers for drug-induced liver injuryChristopher Humphries, James W Dear
Clinical Toxicology (Philadelphia, Pa.)|June 15, 2026
Comment on: "We need a standardized North American acetylcysteine dosing regimen for the treatment of paracetamol (acetaminophen) poisoning" and the response of Mullins and colleaguesChris Humphries, James W Dear
British Journal of Clinical Pharmacology|January 12, 2007
Disease mongering -- a challenge for everyone involved in healthcareJames W Dear, David J Webb
British Journal of Clinical Pharmacology|April 22, 2010
The application of mass-spectrometry-based protein biomarker discovery to theragnosticsJonathan M Street, James W Dear
British Journal of Clinical Pharmacology|March 3, 2017
Should we treat very large paracetamol overdose differently?D Nicholas Bateman, James W Dear
Pageof 14

Showing results (1-10 of 140) with videos related to

Sort By:
Pageof 14
Clinical Toxicology (Philadelphia, Pa.)|October 26, 2010
New marker for paracetamol poisoning-revolution or evolution?James W Dear
British Journal of Clinical Pharmacology|December 6, 2022
Fomepizole should not be used more liberally in paracetamol overdoseJames W Dear
Ebiomedicine|September 8, 2019
Gastrointestinal AEs seen in the POP trial due to SOD mimetic activity of calmangafodipir? - Authors' replyJames W Dear
Journal of the American Society of Nephrology : JASN|April 5, 2014
Urinary exosomes join the fight against infectionJames W Dear
Hepatology (Baltimore, Md.)|March 4, 2018
New biomarkers for drug-induced liver injuryJames W Dear
Clinical Toxicology (Philadelphia, Pa.)|September 28, 2023
Novel biomarkers for drug-induced liver injuryChristopher Humphries, James W Dear
Clinical Toxicology (Philadelphia, Pa.)|June 15, 2026
Comment on: "We need a standardized North American acetylcysteine dosing regimen for the treatment of paracetamol (acetaminophen) poisoning" and the response of Mullins and colleaguesChris Humphries, James W Dear
British Journal of Clinical Pharmacology|January 12, 2007
Disease mongering -- a challenge for everyone involved in healthcareJames W Dear, David J Webb
British Journal of Clinical Pharmacology|April 22, 2010
The application of mass-spectrometry-based protein biomarker discovery to theragnosticsJonathan M Street, James W Dear
British Journal of Clinical Pharmacology|March 3, 2017
Should we treat very large paracetamol overdose differently?D Nicholas Bateman, James W Dear
Pageof 14